Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3975

1.

Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia.

Chen M, Yan R, Zhou K, Li X, Zhang Y, Liu C, Jiang M, Ye H, Meng X, Pang N, Zhao L, Liu J, Xiao W, Hu R, Cui Q, Zhong W, Zhao Y, Zhu M, Lin A, Ruan C, Dai K.

Proc Natl Acad Sci U S A. 2018 Oct 18. pii: 201808217. doi: 10.1073/pnas.1808217115. [Epub ahead of print]

PMID:
30337485
2.

Long-term Complications and Management of Gastrointestinal Bleeding in Multifocal Lymphangioendotheliomatosis.

Shakir AK, Yu Z, Altaf MA.

J Pediatr Hematol Oncol. 2018 Oct 16. doi: 10.1097/MPH.0000000000001324. [Epub ahead of print]

PMID:
30334900
3.

A phase I study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer.

Eyre TA, Collins GP, Gupta A, Coupe N, Sheikh S, Whittaker J, Wang LM, Campo L, Soilleux E, Tysoe F, Cousins R, La Thangue N, Folkes LK, Stratford MRL, Kerr D, Middleton MR.

Cancer. 2018 Oct 17. doi: 10.1002/cncr.31791. [Epub ahead of print]

PMID:
30332497
4.

Waldenström macroglobulinemia: 2018 update on diagnosis, risk stratification, and management.

Gertz MA.

Am J Hematol. 2018 Oct 17. doi: 10.1002/ajh.25292. [Epub ahead of print]

PMID:
30328142
5.

Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?

Xu J, Guo W, Xie L.

BMC Cancer. 2018 Oct 16;18(1):987. doi: 10.1186/s12885-018-4872-x.

6.

Implication of antibodies against human leukocyte antigen in simultaneous presentation of fetal and neonatal alloimmune thrombocytopenia and neutropenia.

Gimferrer I, Teramura G, Gallagher M, Warner P, Ji H, Chabra S.

Transfus Apher Sci. 2018 Sep 29. pii: S1473-0502(18)30251-9. doi: 10.1016/j.transci.2018.09.018. [Epub ahead of print]

PMID:
30318177
7.

Successful Treatment of an Adolescent Male With Severe Refractory Evans Syndrome Using Bortezomib-based Therapy.

Knight T, Ravindranath Y, Callaghan MU.

J Pediatr Hematol Oncol. 2018 Oct 5. doi: 10.1097/MPH.0000000000001325. [Epub ahead of print]

PMID:
30299351
8.

Topotecan monotherapy for the treatment of relapsed small cell lung cancer in elderly patients: A retrospective analysis.

Imai H, Yamada Y, Minemura H, Sugiyama T, Kotake M, Kaira K, Kanazawa K, Nakamura Y, Kasai T, Shibata Y, Kaburagi T, Minato K; Gunma-Ibaragi-Fukushima-Tochigi (GIFT) Group.

Thorac Cancer. 2018 Oct 3. doi: 10.1111/1759-7714.12884. [Epub ahead of print]

PMID:
30281216
9.

A Phase 1/2 Study of evofosfamide, A Hypoxia-Activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma.

Laubach JP, Liu CJ, Raje NS, Yee AJ, Armand P, Schlossman RL, Rosenblatt J, Hedlund J, Martin MG, Reynolds CH, Shain K, Zackon I, Stampleman L, Henrick P, Rivotto BJ, Hornburg K, Dumke H, Chuma S, Savell A, Handisides D, Kroll S, Anderson KC, Richardson PG, Ghobrial IM.

Clin Cancer Res. 2018 Oct 2. pii: clincanres.1325.2018. doi: 10.1158/1078-0432.CCR-18-1325. [Epub ahead of print]

PMID:
30279233
10.

Carfilzomib Induced Tumor Lysis Syndrome and Other Adverse Events.

Sandy EB, Weerasinghe C, Terjanian T.

J Pharm Pract. 2018 Oct 2:897190018802129. doi: 10.1177/0897190018802129. [Epub ahead of print]

PMID:
30278813
11.

Safety of Vinflunine in patients with advanced urothelial carcinoma refractory to platinum-based chemotherapy: a prospective pilot study.

Abdel-Malek R, Shohdy KS, Abbas N, Ismail M, Hamada E, Abdel-Kader Y.

Curr Drug Saf. 2018 Oct 1. doi: 10.2174/1574886313666181001120752. [Epub ahead of print]

PMID:
30277164
12.

Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases.

Zhang W, Wang F, Wang H, Hua B, Feng X, Sun L.

Clin Rheumatol. 2018 Oct 2. doi: 10.1007/s10067-018-4312-y. [Epub ahead of print]

PMID:
30276563
13.

Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report.

Cheng Y, Zhang J, Qin SK, Hua HQ.

Onco Targets Ther. 2018 Sep 18;11:5957-5962. doi: 10.2147/OTT.S176914. eCollection 2018.

14.

Linezolid-induced pure red cell aplasia: a case report and literature review.

Luo Z, Xu N, Wang Y, Huang X, Cao C, Chen L.

J Int Med Res. 2018 Oct 1:300060518800126. doi: 10.1177/0300060518800126. [Epub ahead of print]

PMID:
30270705
15.

Phase I study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreo-retinal lymphoma.

Tun HW, Johnston PB, DeAngelis LM, Atherton PJ, Pederson LD, Koenig PA, Reeder CB, Padula Omuro AM, Schiff D, O'Neill B, Pulido J, Jaeckle KA, Grommes C, Witzig TE.

Blood. 2018 Sep 27. pii: blood-2018-02-835496. doi: 10.1182/blood-2018-02-835496. [Epub ahead of print]

PMID:
30262659
16.

Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.

Park BD, Kumar M, Nagalla S, De Simone N, Aster RH, Padmanabhan A, Sarode R, Rambally S.

Transfus Apher Sci. 2018 Aug;57(4):561-565. doi: 10.1016/j.transci.2018.06.007. Epub 2018 Jun 26. Review.

PMID:
30244713
17.

Assessment of Self-Administration of Romiplostim in Patients with Immune Thrombocytopenic Purpura after Receipt of Home Administration Training Materials: a Cross-Sectional Study.

Schipperus M, Kaiafa G, Taylor L, Wetten S, Kreuzbauer G, Boshier A, Seesaghur A.

Drug Saf. 2018 Sep 19. doi: 10.1007/s40264-018-0723-6. [Epub ahead of print]

PMID:
30232740
18.

Elotuzumab: A Review in Relapsed and/or Refractory Multiple Myeloma.

Lamb YN.

Drugs. 2018 Sep;78(14):1481-1488. doi: 10.1007/s40265-018-0969-4.

PMID:
30232695
19.

Refractory chronic "ITP": When platelet size matters.

Baliakas P, Kättström M, Rossing M, Amini RM.

Clin Case Rep. 2018 Jul 20;6(9):1779-1780. doi: 10.1002/ccr3.1711. eCollection 2018 Sep.

20.

Romiplostim for the Emergency Management of Severe Immune Thrombocytopenia with Intracerebral Hemorrhage.

Gellens R, Habchi S, Freppel S, Couret D, Iacobelli S.

Front Neurol. 2018 Jan 15;8:737. doi: 10.3389/fneur.2017.00737. eCollection 2017.

Supplemental Content

Loading ...
Support Center